Literature DB >> 26748308

Label-free quantitative proteomic analysis of benzo(a)pyrene-transformed 16HBE cells serum-free culture supernatant and xenografted nude mice sera.

Peng Zhao1, Juanling Fu2, Biyun Yao3, Yongrui Jia4, Hongtao Zhang3, Xuehui Li3, Lisha Dong3, Ya Gao3, Wenli Liu3, Wen Chen5, Zongcan Zhou6.   

Abstract

To screen potential biomarkers of benzo(a)pyrene (BaP)-induced lung cancer, the proteomic profiles of BaP-transformed 16HBE cell line T-16HBE-C1 cells serum-free culture supernatant and xenografted nude mice sera were compared with those of 16HBE group by utilizing label-free quantitative proteomic strategy. By employing nano-LC-MS/MS technology followed by MaxQuant and Perseus processing, 489 differentially expressed proteins were identified between T-16HBE-C1 and 16HBE cells serum-free culture supernatant, and 49 significantly up-regulated proteins were identified in T-16HBE-C1 xenografted nude mice sera. Three proteins neuropilin-2 (NRP2), clusterin (CLU) and A-kinase anchor protein 12 (AKAP12) were up-regulated in the serum-free culture supernatant of T-16HBE-C1 cells. These 3 human proteins were present in the sera of nude mice xenografted with T-16HBE-C1 cells, but were undetectable in mice xenografted with 16HBE cells. The proteomic results of NRP2 and AKAP12 were confirmed by Western blotting and enzyme-linked immunosorbent assays, respectively. Moreover, the serum NRP2 levels were significantly elevated at the 4th day after tumor cell implantation and showed good positive correlation with tumor growth characterized by tumor volume. In conclusion, serum NRP2, CLU and AKAP12 could be potential biomarkers of BaP-induced lung cancer. The proteomic results will gain deeper insights into the mechanisms of BaP-induced carcinogenesis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AKAP12; Benzo(a)pyrene; CLU; Label-free quantitative proteomics; NRP2; T-16HBE-C1 cells

Mesh:

Substances:

Year:  2015        PMID: 26748308     DOI: 10.1016/j.cbi.2015.12.017

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  3 in total

1.  A microfluidic device for studying chemotaxis mechanism of bacterial cancer targeting.

Authors:  Jing Song; Yu Zhang; Chengqian Zhang; Xiaohui Du; Zhe Guo; Yanbin Kuang; Yingyan Wang; Peng Wu; Kun Zou; Lijuan Zou; Jianxin Lv; Qi Wang
Journal:  Sci Rep       Date:  2018-04-23       Impact factor: 4.379

2.  Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Β-catenin pathway.

Authors:  Hua Gong; Weihua Chen; Lanhua Mi; Dan Wang; Youkang Zhao; Chao Yu; Aiguang Zhao
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

Review 3.  The multiple roles and therapeutic potential of clusterin in non-small-cell lung cancer: a narrative review.

Authors:  Juofang Tan; Wei Guo; Su Yang; Dingpei Han; Hecheng Li
Journal:  Transl Lung Cancer Res       Date:  2021-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.